← All stocks

Ensysce Biosciences, Inc.

ENSC Net buying

CIK 0001716947 #5346 in the set updated 17 Sep 2026

Bought (120 mo)

$11.22M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

1 of 1 sales

Net

+$11.22M

+$11.22M against sales at will

By person

10 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

HG Vora Capital Management, LLC entity

10% owner

$10.00M (1)

—

+$10.00M

3,462,500

$1.71M

−2.6%

GOWER BOB G

Director

$1.17M (6)

—

+$1.17M

916,740

$453.79K

—

Kirkpatrick Lynn

Chief Executive Officer

$48.30K (2)

—

+$48.30K

381,851

$189.02K

—

MORGAN STANLEY

10% owner

—

— (1)

$0.00

−100.0%

Chang William H

Director

—

2,595,640

$1.28M

—

WEIL A LORNE

10% owner

—

1,134,742

$561.70K

−31.8%

Silvers Daniel B.

10% owner

—

1,128,370

$558.54K

−32.0%

Peng George

Former officer

—

87,014

$43.07K

−13.8%

Carrera Eric

Former officer

—

54,701

$27.08K

−15.2%

Humphrey David Carl

Chief Financial Officer

—

50,000

$24.75K

—

No percentages here. This company's share count has moved by a factor of 13.9 over the window, from 1,405,134 to 19,574,014 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 47

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 1

Shares from compensation/vesting 13,028,233

Sales filed before the plan box existed 1

History held since 5 Dec 2017